ENDPOINTS

AstraZeneca buys FibroGen’s China unit for local control of anemia drug

AstraZeneca is furthering its presence in China by gaining complete control of FibroGen's subsidiary in the country for about $160 million. The Thursday morning move gives the UK pharma giant a ...

Feb 20, 2025 - 13:38
 0
AstraZeneca buys FibroGen’s China unit for local control of anemia drug
AstraZeneca is furthering its presence in China by gaining complete control of FibroGen's subsidiary in the country for about $160 million. The Thursday morning move gives the UK pharma giant a ...
Read More

Tags:

Previous Article

BridgeBio’s heart disease drug Attruby sails past prescription estimates

Next Article

How to watch 'Museum Alive with David Attenborough', as US streaming begins for ...

Related Posts

Hims’ Super Bowl ad has drawn criticism from lawmakers — and now Novo Nordisk

Hims’ Super Bowl ad has drawn criticism from lawmakers ...

Feb 10, 2025  0

AstraZeneca takes $753M charge on abandoned complement drug from Alexion deal

AstraZeneca takes $753M charge on abandoned complement ...

Feb 9, 2025  0

Vertex operations chief Stuart Arbuckle to retire

Vertex operations chief Stuart Arbuckle to retire

Feb 11, 2025  0